Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent
- PMID: 28589549
- DOI: 10.1002/jmri.25789
Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent
Comment in
-
Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent".J Magn Reson Imaging. 2018 Mar;47(3):862-863. doi: 10.1002/jmri.25788. Epub 2017 Jun 5. J Magn Reson Imaging. 2018. PMID: 28580722 No abstract available.
Comment on
-
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.J Magn Reson Imaging. 2015 Nov;42(5):1249-58. doi: 10.1002/jmri.24897. Epub 2015 Apr 6. J Magn Reson Imaging. 2015. PMID: 25851028
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
